Australia Moves Forward With Teen Social Media Ban as Platforms Begin Lockouts 
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment 
Taiwan Signals Openness to Renew Ties with Honduras as Election Unfolds 
FDA Memo Raises Questions About Possible COVID-19 Vaccine Links to Rare Child Deaths 
Pfizer Boosts Bid for Metsera Amid Intensifying Rivalry with Novo Nordisk in Obesity Drug Market 
Minneapolis Leaders Push Back as Trump Escalates Rhetoric Against Somali Community 
States Sue Trump Administration Over SNAP Restrictions for Legal Immigrants 
Trump Administration Tightens H-1B Visa Vetting With New Focus on Free Speech and Censorship 
National Guard Member Killed in White House-Area Shooting Sparks Terror Probe and Immigration Review 
Trump Administration Halts Immigration, Green Card, and Citizenship Processing for 19 Countries 
Trump Administration to Secure Equity Stake in Pat Gelsinger’s XLight Startup 
IMF Deputy Dan Katz Visits China as Key Economic Review Nears 
U.S. Defense Chief Pete Hegseth Defends Controversial Second Strike on Suspected Drug-Smuggling Vessel 
Trump Warns Drug-Trafficking Nations as Colombia’s Petro Issues Strong Rebuttal 
Trump’s Name Appears on U.S. Institute of Peace Ahead of Rwanda–Congo Deal Signing 
U.S. President Donald Trump has requested a safety review of abortion pills, according to Health and Human Services Secretary Robert F. Kennedy Jr. in an interview with Fox News on Thursday. The move signals a potential policy shift as Trump evaluates whether to tighten regulations on the medication.
Kennedy Jr. stated that the administration aims to ensure public safety by thoroughly assessing the risks and benefits of abortion pills. He emphasized that no decision has been made regarding restrictions and that the findings of the study will guide future policies.
The announcement has sparked strong reactions from advocacy groups on both sides of the abortion debate. Pro-life organizations support the study, arguing that stricter rules could protect women's health. Meanwhile, pro-choice advocates criticize the move, expressing concerns that it could limit access to safe reproductive healthcare.
This development comes as abortion rights remain a highly contested topic in the U.S., with recent legal battles over reproductive laws drawing national attention. The outcome of the study could significantly impact abortion pill access and influence ongoing state-level debates.
As the administration reviews the data, both supporters and opponents are closely monitoring the situation. Kennedy Jr. assured that transparency and scientific evidence would be at the forefront of any policy changes.
The decision on whether to impose new restrictions will follow the completion of the study, though no timeline has been provided. The White House has yet to release further comments.
This review highlights the ongoing political and social tensions surrounding reproductive rights, with potential implications for healthcare policies ahead of the upcoming election cycle.
